ENDONOVO THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2018 | $-2.9M | $-2.9M | $9.0K | — |
| FY2019 | $-2.5M | $-2.5M | $2.6K | $31.0K |
| FY2020 | $-741.6K | $-741.6K | — | $57.4K |
| FY2021 | $-986.6K | $-986.6K | — | $0 |
| FY2022 | $-678.8K | $-678.8K | — | — |